Quick Answer
EXAGEN INC. reported Total Revenue of $66.58 million for the year ending 2025.
- EXAGEN INC. showed an increase of +19.7% in Total Revenue from 2024 to 2025.
- This data is from EXAGEN INC.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $8.22 million | Q1 2019: $9.26 million | Q2 2019: $10.47 million | Q3 2019: $10.44 million | Q1 2020: $9.58 million | Q2 2020: $8.95 million | Q3 2020: $10.78 million | Q1 2021: $10.59 million | Q2 2021: $12.77 million | Q3 2021: $12.25 million | Q1 2022: $10.39 million | Q2 2022: $7.61 million | Q3 2022: $14.73 million | Q1 2023: $11.23 million | Q2 2023: $14.14 million | Q3 2023: $13.42 million | Q1 2024: $14.42 million | Q2 2024: $15.06 million | Q3 2024: $12.51 million | Q1 2025: $15.50 million | Q2 2025: $17.20 million | Q3 2025: $17.24 million.
- Over the full 8 years of available data (2018 to 2025), EXAGEN INC.'s Total Revenue has grown by 105.2%.
- Historical annual values: Fiscal year 2025: $66.58 million | Fiscal year 2024: $55.64 million | Fiscal year 2023: $52.55 million | Fiscal year 2022: $45.56 million | Fiscal year 2021: $48.30 million | Fiscal year 2020: $41.98 million | Fiscal year 2019: $40.39 million | Fiscal year 2018: $32.44 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: